Zugmaier, G., Topp, M. S., Alekar, S., Viardot, A., Horst, H., Neumann, S., . . . Klinger, M. (2014). Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia. Nature Publishing Group.
Citação norma ChicagoZugmaier, G., et al. Long-term Follow-up of Serum Immunoglobulin Levels in Blinatumomab-treated Patients With Minimal Residual Disease-positive B-precursor Acute Lymphoblastic Leukemia. Nature Publishing Group, 2014.
MLA CitationZugmaier, G., et al. Long-term Follow-up of Serum Immunoglobulin Levels in Blinatumomab-treated Patients With Minimal Residual Disease-positive B-precursor Acute Lymphoblastic Leukemia. Nature Publishing Group, 2014.